DC Funds, LP
- SEC CIK
- 0001869028
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 3
- 0 vs. Q3 2021
- Portfolio value
- $16.9M
- −$8.58M (−33.7%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | ADS | 642,204 | $7.13M | 42.2% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 580,902 | $6.92M | 41.0% | −8,200−1.4% | Reduced | History |
| TCRXTScan Therapeutics, Inc. | COM | 630,000 | $2.83M | 16.8% | 00.0% | Unchanged | History |